Craig P. Webb

5.2k total citations · 1 hit paper
46 papers, 3.7k citations indexed

About

Craig P. Webb is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Craig P. Webb has authored 46 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Craig P. Webb's work include Liver physiology and pathology (9 papers), Cancer Genomics and Diagnostics (5 papers) and Fibroblast Growth Factor Research (4 papers). Craig P. Webb is often cited by papers focused on Liver physiology and pathology (9 papers), Cancer Genomics and Diagnostics (5 papers) and Fibroblast Growth Factor Research (4 papers). Craig P. Webb collaborates with scholars based in United States, United Kingdom and Japan. Craig P. Webb's co-authors include George F. Vande Woude, Michael Jeffers, Marianne Oskarsson, Nicholas S. Duesbery, Stephen H. Leppla, Kurt R. Klimpel, Natalie G. Ahn, Terry D. Copeland, Kenji Fukasawa and V M Gordon and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Craig P. Webb

45 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Proteolytic Inactivation of MAP-Kinase-Kinase by Anthrax Lethal Factor

1998 824 citations Nicholas S. Duesbery, Craig P. Webb et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Craig P. Webb United States	27	2.4k	688	630	623	524	46	3.7k
Keng‐Hsin Lan Taiwan	33	1.4k 0.6×	517 0.8×	225 0.4×	753 1.2×	1.2k 2.3×	129	3.7k
El–Nasir Lalani United Kingdom	38	2.7k 1.1×	555 0.8×	699 1.1×	1.1k 1.7×	396 0.8×	119	5.1k
Elwyn Loh United States	28	2.0k 0.8×	446 0.6×	526 0.8×	929 1.5×	326 0.6×	66	4.0k
Ana M. Rojas Spain	37	2.3k 1.0×	350 0.5×	1.3k 2.1×	455 0.7×	199 0.4×	114	5.2k
Wolfgang Sommergruber Austria	38	2.7k 1.1×	275 0.4×	849 1.3×	1.5k 2.4×	192 0.4×	78	5.3k
John Pedersen Australia	34	1.6k 0.7×	296 0.4×	854 1.4×	752 1.2×	117 0.2×	90	3.6k
Ravid Straussman Israel	20	3.7k 1.5×	358 0.5×	511 0.8×	1.8k 2.9×	141 0.3×	28	5.3k
Robert H. Whitehead Australia	33	2.0k 0.8×	549 0.8×	270 0.4×	976 1.6×	152 0.3×	72	4.0k
Franco M. Buonaguro Italy	34	1.3k 0.5×	205 0.3×	294 0.5×	719 1.2×	249 0.5×	111	3.4k
Serge Jothy Canada	37	2.1k 0.9×	343 0.5×	458 0.7×	1.3k 2.1×	143 0.3×	80	4.8k

Countries citing papers authored by Craig P. Webb

Since Specialization

Citations

This map shows the geographic impact of Craig P. Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig P. Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig P. Webb more than expected).

Fields of papers citing papers by Craig P. Webb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig P. Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig P. Webb. The network helps show where Craig P. Webb may publish in the future.

Co-authorship network of co-authors of Craig P. Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Craig P. Webb. A scholar is included among the top collaborators of Craig P. Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig P. Webb. Craig P. Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monsma, David J., David Cherba, Sean Vance, et al.. (2014). Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance. Pediatric Blood & Cancer. 61(9). 1570–1577. 16 indexed citations

Poisson, Laila, David Cherba, Craig P. Webb, et al.. (2014). Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation. Neoplasia. 16(3). 193–206.e25. 123 indexed citations

Paoloni, Melissa, Craig P. Webb, Christina Mazcko, et al.. (2014). Prospective Molecular Profiling of Canine Cancers Provides a Clinically Relevant Comparative Model for Evaluating Personalized Medicine (PMed) Trials. PLoS ONE. 9(3). e90028–e90028. 26 indexed citations

Peacock, Jacqueline D., et al.. (2013). Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors. Journal of Translational Medicine. 11(1). 213–213. 14 indexed citations

Mooney, Marie R., Jeffrey P. Bond, Noel R. Monks, et al.. (2013). Comparative RNA-Seq and Microarray Analysis of Gene Expression Changes in B-Cell Lymphomas of Canis familiaris. PLoS ONE. 8(4). e61088–e61088. 47 indexed citations

Sholler, Giselle L. Saulnier, William S. Ferguson, Genevieve Bergendahl, et al.. (2012). A Pilot Trial Testing the Feasibility of Using Molecular-Guided Therapy in Patients with Recurrent Neuroblastoma. Journal of Cancer Therapy. 3(5). 602–612. 12 indexed citations

Monsma, David J., Noel R. Monks, David Cherba, et al.. (2012). Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue. Journal of Translational Medicine. 10(1). 125–125. 55 indexed citations

Lee, Chih-Shia, Karl Dykema, David Cherba, et al.. (2011). MEK2 Is Sufficient but Not Necessary for Proliferation and Anchorage-Independent Growth of SK-MEL-28 Melanoma Cells. PLoS ONE. 6(2). e17165–e17165. 21 indexed citations

Melnik, Marianne K., Craig P. Webb, Alan Campbell, et al.. (2010). Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer. Molecular Cancer Therapeutics. 9(8). 2423–2429. 14 indexed citations

10.

Ranade, Aarati R., et al.. (2010). MicroRNA 92a-2*: A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer. Journal of Thoracic Oncology. 5(8). 1273–1278. 105 indexed citations

11.

Wang, Xiaoting, Shuangshuang Wang, Xiaojun Tang, et al.. (2010). Development and evaluation of monoclonal antibodies against phosphatidylethanolamine binding protein 1 in pancreatic cancer patients. Journal of Immunological Methods. 362(1-2). 151–160. 10 indexed citations

12.

Rao, Donald D., Phillip B. Maples, Neil Senzer, et al.. (2010). Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference. Cancer Gene Therapy. 17(11). 780–791. 36 indexed citations

13.

Ivanov, Sergey V., J. Miller, Robert Lucito, et al.. (2008). Genomic events associated with progression of pleural malignant mesothelioma. International Journal of Cancer. 124(3). 589–599. 59 indexed citations

14.

Kuick, Rork, David E. Misek, David J. Monsma, et al.. (2007). Discovery of cancer biomarkers through the use of mouse models. Cancer Letters. 249(1). 40–48. 26 indexed citations

15.

Agur, Zvia, et al.. (2006). Using a Novel Computer Technology for Tailoring Targeted and Chemotherapeutic Drug Schedules to the Individual Patient. Clinical Cancer Research. 12. 1 indexed citations

16.

Webb, Craig P. & Harvey I. Pass. (2004). Translation research: from accurate diagnosis to appropriate treatment. Journal of Translational Medicine. 2(1). 35–35. 25 indexed citations

17.

Webb, Craig P., Hsiao‐Man Ivy Yu, Xueke You, et al.. (2001). Normal and Malignant Prostate Epithelial Cells Differ in Their Response to Hepatocyte Growth Factor/Scatter Factor. American Journal Of Pathology. 159(2). 579–590. 80 indexed citations

18.

Webb, Craig P. & George F. Vande Woude. (2001). Animal models for Ras-induced metastasis. Methods in enzymology on CD-ROM/Methods in enzymology. 333. 318–329. 3 indexed citations

19.

Bernard, Gordon R., George Sopko, Frank B. Cerra, et al.. (2000). Pulmonary Artery Catheterization and Clinical Outcomes. JAMA. 283(19). 2568–2568. 114 indexed citations

20.

Taylor, Gregory A., et al.. (1998). Decreased fibronectin expression in Met/HGF-mediated tumorigenesis. Oncogene. 17(9). 1179–1183. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact